APA (7th ed.) Citation

JA, Z., XM, M., A, R., & AY, Z. (2022). Systemic and Ocular Adverse Events with Intravitreal Anti-VEGF Therapy Used in the Treatment of Diabetic Retinopathy: A Review. Current diabetes reports, 22(10), 525. https://doi.org/10.1007/s11892-022-01491-y

Chicago Style (17th ed.) Citation

JA, Zehden, Mortensen XM, Reddy A, and Zhang AY. "Systemic and Ocular Adverse Events with Intravitreal Anti-VEGF Therapy Used in the Treatment of Diabetic Retinopathy: A Review." Current Diabetes Reports 22, no. 10 (2022): 525. https://doi.org/10.1007/s11892-022-01491-y.

MLA (9th ed.) Citation

JA, Zehden, et al. "Systemic and Ocular Adverse Events with Intravitreal Anti-VEGF Therapy Used in the Treatment of Diabetic Retinopathy: A Review." Current Diabetes Reports, vol. 22, no. 10, 2022, p. 525, https://doi.org/10.1007/s11892-022-01491-y.